Respiratory syncytial virus: reverse genetics and vaccine strategies.
Collins
Peter L
PL
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0720, USA. pcollins@niaid.nih.gov
Murphy
Brian R
BR
D000818:Animals; D000956:Antigens, Viral / Q000235:genetics / Q000276:immunology*; D005822:Genetic Vectors; D006801:Humans; D018357:Respiratory Syncytial Virus Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D022261:Respiratory Syncytial Virus Vaccines / Q000009:adverse effects / Q000276:immunology*; D018113:Respiratory Syncytial Virus, Human / Q000235:genetics / Q000276:immunology*; D012136:Respiratory Syncytial Viruses / Q000235:genetics / Q000276:immunology; D014613:Vaccines, Attenuated / Q000276:immunology; D019444:Vaccines, DNA / Q000009:adverse effects / Q000276:immunology*; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology*
D000956:Antigens, Viral; D022261:Respiratory Syncytial Virus Vaccines; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA; D014764:Viral Proteins